Back to Search Start Over

Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma

Authors :
Cukier, Alberto
Jacob, Cristina Miuki Abe [UNIFESP]
Rosario Filho, Nelson Augusto
Fiterman, Jussara
Vianna, Elcio Oliveira
Hetzel, Jorge Lima
Neis, Marcio Abreu
Fiss, Elie
Castro, Fábio Fernandes Morato
Fernandes, Ana Luisa Godoy [UNIFESP]
Stirbulov, Roberto
Pizzichini, Emilio
AIR Brazilian Study Grp
Universidade de São Paulo (USP)
Univ Fed Parana
Pontificia Univ Catolica Rio Grande do Sul
Univ S Paulo
Santa Casa Misericordia Porto Alegre
Ctr Paulista Invest Clin
Fac Med ABC
Inst Pesquisa Clin Med Avancada
Universidade Federal de São Paulo (UNIFESP)
Santa Casa Sch Med Sci São Paulo
Universidade Federal de Santa Catarina (UFSC)
Universidade Estadual Paulista (Unesp)
Universidade Federal do Paraná (UFPR)
Santa Casa Sch Med Sci Sao Paulo
Source :
Repositório Institucional da UNIFESP, Universidade Federal de São Paulo (UNIFESP), instacron:UNIFESP, Web of Science, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP
Publisher :
Elsevier Ltd.

Abstract

Made available in DSpace on 2014-12-03T13:08:46Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-09-01Bitstream added on 2014-12-03T13:23:26Z : No. of bitstreams: 1 WOS000330271600006.pdf: 653705 bytes, checksum: 7169480c3bce90ef10850a2c11b21d68 (MD5) This 12-week study compared the efficacy and safety of a fixed combination of fluticasone propionate plus formoterol (FL/F) 250/12 mu g b.i.d. administered via a dry powder inhaler (DPI) (Libbs Farmaceutica, Brazil) to a combination of budesonide plus formoterol (BD/F) 400/12 mu g b.i.d. After a 2-week run-in period (in which all patients were treated exclusively with budesonide plus formoterol), patients aged 12-65 years of age (N = 196) with uncontrolled asthma were randomized into an actively-controlled, open-labeled, parallel-group, multicentre, phase III study. The primary objective was to demonstrate non-inferiority, measured by morning peak expiratory flow (mPEF).The non-inferiority was demonstrated. A statistically significant improvement from baseline was observed in both groups in terms of lung function, asthma control, and the use of rescue medication. FL/F demonstrated a statistical superiority to BD/F in terms of lung function (FEV1) (p = 0.01) and for asthma control (p = 0.02). Non-significant between-group differences were observed with regards to exacerbation rates and adverse events.In uncontrolled or partly controlled asthma patients, the use of a combination of fluticasone propionate plus formoterol via DPI for 12-weeks was non-inferior and showed improvements in FEV1 and asthma control when compared to a combination of budesonide plus formoterol. (Clinical Trial number: ISRCTN60408425). (C) 2013 Elsevier Ltd. All rights reserved. Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, BR-05403000 Sao Paulo, Brazil State Univ Sao Paulo, Dept Pediat, BR-05403000 Sao Paulo, Brazil Univ Fed Parana, Dept Pediat, BR-80060240 Curitiba, Parana, Brazil Pontificia Univ Catolica Rio Grande do Sul, Sao Lucas Hosp, Ctr Pesquisa Clin, BR-90610000 Porto Alegre, RS, Brazil Univ S Paulo, Med Sch Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil Santa Casa Misericordia Porto Alegre, BR-90035074 Porto Alegre, RS, Brazil Ctr Paulista Invest Clin, BR-04266010 Sao Paulo, Brazil Fac Med ABC, BR-09061650 Santo Andre, SP, Brazil Inst Pesquisa Clin Med Avancada, BR-05437000 Sao Paulo, Brazil Univ Fed Sao Paulo, BR-04062023 Sao Paulo, Brazil Santa Casa Sch Med Sci Sao Paulo, BR-01221900 Sao Paulo, Brazil Univ Fed Santa Catarina, BR-88040970 Florianopolis, SC, Brazil State Univ Sao Paulo, Dept Pediat, BR-05403000 Sao Paulo, Brazil

Details

Language :
English
ISSN :
09546111
Issue :
9
Database :
OpenAIRE
Journal :
Respiratory Medicine
Accession number :
edsair.doi.dedup.....e45b70160ecab006659601d186988410
Full Text :
https://doi.org/10.1016/j.rmed.2013.06.018